Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Crippa

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Neuro-Oncology|November 19, 2015
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomasUlrich Roelcke, Matthias T Wyss, Martha Nowosielski, et al.
Clinical Genitourinary Cancer|October 5, 2015
Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future DirectionsAndrea Necchi, Nicola Nicolai, Alessandra Alessi, et al.
Tumori|September 10, 2015
FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary resultsAlessandra Alessi, Fabio Martinelli, Barbara Padovano, et al.
Cancer|July 29, 2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantationAnna Dodero, Roberto Crocchiolo, Francesca Patriarca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Response to sunitinib malate in advanced alveolar soft part sarcomaSilvia Stacchiotti, Elena Tamborini, Andrea Marrari, et al.
BMC Cancer|April 17, 2015
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case reportMarcella Tazzari, Elena Palassini, Barbara Vergani, et al.
Urologia|February 21, 2012
[The treatment of early-stage germ cell tumors of the testis (GCTT)]Roberto Salvioni, Nicola Nicolai, Andrea Necchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2014
Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin MicrospheresCarlo Chiesa, Bieke Lambert, Marco Maccauro, et al.
La Radiologia Medica|December 19, 2018
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapyAlessandra Alessi, Alice Lorenzoni, Anna Cavallo, et al.
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Neuro-Oncology|November 19, 2015
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomasUlrich Roelcke, Matthias T Wyss, Martha Nowosielski, et al.
Clinical Genitourinary Cancer|October 5, 2015
Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future DirectionsAndrea Necchi, Nicola Nicolai, Alessandra Alessi, et al.
Tumori|September 10, 2015
FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary resultsAlessandra Alessi, Fabio Martinelli, Barbara Padovano, et al.
Cancer|July 29, 2010
Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantationAnna Dodero, Roberto Crocchiolo, Francesca Patriarca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Response to sunitinib malate in advanced alveolar soft part sarcomaSilvia Stacchiotti, Elena Tamborini, Andrea Marrari, et al.
BMC Cancer|April 17, 2015
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case reportMarcella Tazzari, Elena Palassini, Barbara Vergani, et al.
Urologia|February 21, 2012
[The treatment of early-stage germ cell tumors of the testis (GCTT)]Roberto Salvioni, Nicola Nicolai, Andrea Necchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2014
Pretreatment Dosimetry in HCC Radioembolization with (90)Y Glass Microspheres Cannot Be Invalidated with a Bare Visual Evaluation of (99m)Tc-MAA Uptake of Colorectal Metastases Treated with Resin MicrospheresCarlo Chiesa, Bieke Lambert, Marco Maccauro, et al.
La Radiologia Medica|December 19, 2018
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapyAlessandra Alessi, Alice Lorenzoni, Anna Cavallo, et al.
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
Pageof 4